News

Gladstone in the News November 18, 2025

Late-Onset Parkinson’s Linked to Mitochondrial Protein CHCHD2

Inside Precision Medicine—A new study by Gladstone Investigator Ken Nakamura has found that a mitochondrial protein, CHCHD2, can drive a sequence of cellular events that lead to the development Parkinson’s disease.

Gladstone Experts Parkinson’s Disease Neurological Disease Nakamura Lab

Gladstone in the News November 17, 2025

Neurons Repair CRISPR Damage With Unique Timing

CRISPR Medicine News—Gladstone Investigator Bruce Conklin showed how manipulating DNA repair responses in neurons after CRISPR editing can direct outcomes and improve editing efficiency.

Gladstone Experts Neurological Disease Conklin Lab CRISPR/Gene Editing

Article November 17, 2025

The Genome Editing Playbook Is Different in Neurons

The striking findings of a new study could influence how gene therapies are designed for many genetic diseases.

News Release Research (Publication) Neurological Disease Conklin Lab Doudna Lab CRISPR/Gene Editing

Gladstone in the News November 15, 2025

Cracking the Code of Life from the Top of Potrero Hill

Potrero View—This profile of Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, describes how she became one of the world’s leading scientists in computational genomics, and how her team is using artificial intelligence to decode the fundamental language of life itself.

Gladstone Experts Pollard Lab

Article November 14, 2025

Evidence Builds for Disrupted Mitochondria as Cause of Parkinson’s

A new study from Gladstone Institutes strengthens the links between energy breakdown in cells and the onset of Parkinson’s, potentially illuminating new paths for treatment.

News Release Research (Publication) Parkinson’s Disease Neurological Disease Nakamura Lab

Article November 13, 2025

Researchers Reveal Intricate Control System for Key Immune Gene

Scientists learn to fine-tune a gene that is centrally involved in regulating the immune system, offering potential clues for future autoimmunity and cancer treatments.

News Release Research (Publication) Autoimmune Diseases Cancer Genomic Immunology Marson Lab

Article November 5, 2025

Deepak Srivastava Selected to Deliver American Heart Association’s Distinguished Scientist Lecture

Srivastava will present at the American Heart Association’s Scientific Sessions 2025 in New Orleans; the lectureship is a major recognition of excellence by the association.

News Release Cardiovascular Disease Srivastava Lab Genomics Stem Cells/iPSCs

Gladstone in the News November 4, 2025

Azalea Therapeutics Launches With $82 Million Financing to Redefine Precision Genomic Medicines by Engineering Cells Directly Inside Each Patient

Azalea Therapeutics—Gladstone Investigators Jennifer Doudna and Justin Eyquem founded a new company to advance next-generation genomic medicines.

Business Development Gladstone Experts Doudna Lab Eyquem Lab

Video November 3, 2025

Science in Seconds | Researchers Pinpoint Key Gene Behind Heart Defects in Down Syndrome

In this video, Gladstone scientists share how they used stem cells, gene editing, and AI to identify a gene driving heart defects in Down syndrome—and how reducing its levels in mice restored normal heart development, offering hope for future treatments

Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab AI Big Data CRISPR/Gene Editing Human Genetics Stem Cells/iPSCs

Gladstone in the News November 3, 2025

Heart-on-a-Chip May Lead to New Treatments for Heart Failure

UC Berkeley Engineering—Researchers from Gladstone, including Gladstone President and Investigator Deepak Srivastava, were part of a team that discovered a way to efficiently deliver therapeutic messenger RNA into heart muscle cells, overcoming a bottleneck in heart-failure therapeutics that could open the door to novel, lifesaving treatments.

Gladstone Experts Heart Failure Cardiovascular Disease Srivastava Lab

Gladstone in the News October 30, 2025

The Silicon Cell

Science—AI cell models that emulate their living counterparts hold potential to transform biomedicine, and Gladstone Investigator Christina Theodoris has been at the forefront of this effort with her platform for predicting gene interactions. (Subscription required.)

Gladstone Experts Theodoris Lab AI

Article October 28, 2025

Rewriting Cellular Instructions to Make Better Tumor-Fighting Immunotherapies

A powerful scientific platform opens new possibilities for treating cancer, autoimmune diseases, and other conditions in which reprogrammed T cells could provide a benefit to patients.

News Release Research (Publication) Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing

Gladstone in the News October 28, 2025

New COVID Vaccine Says It’s for the ‘Senior Class’—Does It Reduce Side Effects?

San Francisco Chronicle—Gladstone Investigator Nadia Roan shares insights on the new, lower-dose COVID vaccine that’s being marketed to adults 65 and older, and comments on what to consider when choosing between the new vaccine and the previous version. (Subscription required.)

Gladstone Experts COVID-19 Roan Lab

Gladstone in the News October 28, 2025

“Vascular Biology” Featuring Dr. Juan Melero-Martin

The Stem Cell Podcast—

Gladstone Experts Congenital Heart Disease Cardiovascular Disease Pollard Lab Srivastava Lab

Article October 27, 2025

Meet Gladstone: Shijie Wang

Shijie Wang, a postdoctoral scholar in Steve Finkbeiner’s lab, uses artificial intelligence, robotics, and stem cell technologies to uncover how brain cells die in neurodegenerative diseases like Alzheimer’s and Parkinson’s.

Profile Neurological Disease Finkbeiner Lab AI Robotic Microscopy